204 related articles for article (PubMed ID: 23140165)
1. Edible vaccine: a new platform for the development of malaria vaccine.
Kumar CS; Deepesh G; Mahavir Y; Archana T
Crit Rev Eukaryot Gene Expr; 2012; 22(3):243-8. PubMed ID: 23140165
[TBL] [Abstract][Full Text] [Related]
2. Malaria vaccine development using synthetic peptides as a technical platform.
Corradin G; Céspedes N; Verdini A; Kajava AV; Arévalo-Herrera M; Herrera S
Adv Immunol; 2012; 114():107-49. PubMed ID: 22449780
[TBL] [Abstract][Full Text] [Related]
3. Platform for Plasmodium vivax vaccine discovery and development.
Valencia SH; Rodríguez DC; Acero DL; Ocampo V; Arévalo-Herrera M
Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1(Suppl 1):179-92. PubMed ID: 21881773
[TBL] [Abstract][Full Text] [Related]
4. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
5. Current developments in malaria transmission-blocking vaccines.
Stowers A; Carter R
Expert Opin Biol Ther; 2001 Jul; 1(4):619-28. PubMed ID: 11727498
[TBL] [Abstract][Full Text] [Related]
6. The use of transgenic parasites in malaria vaccine research.
Othman AS; Marin-Mogollon C; Salman AM; Franke-Fayard BM; Janse CJ; Khan SM
Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525963
[TBL] [Abstract][Full Text] [Related]
7. Overview: immunology of malaria and progress in malaria vaccine development.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
[No Abstract] [Full Text] [Related]
8. The March Toward Malaria Vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S319-33. PubMed ID: 26590432
[TBL] [Abstract][Full Text] [Related]
9. [Malaria vaccine research].
Sellioğlu B
Mikrobiyol Bul; 1986 Jan; 20(1):37-41. PubMed ID: 3523172
[TBL] [Abstract][Full Text] [Related]
10. Transmission blocking malaria vaccines: Assays and candidates in clinical development.
Sauerwein RW; Bousema T
Vaccine; 2015 Dec; 33(52):7476-82. PubMed ID: 26409813
[TBL] [Abstract][Full Text] [Related]
11. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
Hisaeda H; Yasutomo K
J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
[TBL] [Abstract][Full Text] [Related]
12. Malaria vaccine developments.
Moorthy VS; Good MF; Hill AV
Lancet; 2004 Jan; 363(9403):150-6. PubMed ID: 14726170
[TBL] [Abstract][Full Text] [Related]
13. A Plasmodium vivax Plasmid DNA- and Adenovirus-Vectored Malaria Vaccine Encoding Blood-Stage Antigens AMA1 and MSP1
Obaldia N; Stockelman MG; Otero W; Cockrill JA; Ganeshan H; Abot EN; Zhang J; Limbach K; Charoenvit Y; Doolan DL; Tang DC; Richie TL
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28179404
[TBL] [Abstract][Full Text] [Related]
14. Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses.
White M; Amino R; Mueller I
Trends Parasitol; 2017 Apr; 33(4):260-263. PubMed ID: 28077251
[TBL] [Abstract][Full Text] [Related]
15. Transmission blocking malaria vaccines.
Carter R
Vaccine; 2001 Mar; 19(17-19):2309-14. PubMed ID: 11257353
[TBL] [Abstract][Full Text] [Related]
16. Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.
Chen Q; Liang W; Qian F; Qian B; Cao J; Zhang D; Xu Y; Tang L
Parasite Immunol; 2016 Oct; 38(10):635-41. PubMed ID: 27493141
[TBL] [Abstract][Full Text] [Related]
17. Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit.
Valderrama-Aguirre A; Quintero G; Gómez A; Castellanos A; Pérez Y; Méndez F; Arévalo-Herrera M; Herrera S
Am J Trop Med Hyg; 2005 Nov; 73(5 Suppl):16-24. PubMed ID: 16291762
[TBL] [Abstract][Full Text] [Related]
18. Genetically attenuated malaria parasites as vaccines.
Vaughan AM; Kappe SHI
Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
[No Abstract] [Full Text] [Related]
19. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
20. New candidate vaccine neutralizes all tested strains of malaria parasite.
Hum Vaccin Immunother; 2012 Feb; 8(2):153-4. PubMed ID: 22745944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
